Paclitaxel-eluting stents effective in various subgroups

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1488, 2005-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel-eluting stents reduce restenosis

By  

Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Paclitaxel-eluting stents reduce restenosis

By  

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Paclitaxel-Eluting Stents: Current Clinical Experience

By Eberhard Grube   Lutz Buellesfeld  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 355-360

Adis International

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 225-228

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel-eluting stent safe, effective against restenosis

By  

Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite